{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:47:51Z","timestamp":1793029671445,"version":"4.5.0"},"reference-count":83,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T00:00:00Z","timestamp":1447891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>More than 6.5 million patients are burdened by the physical, cognitive, and psychosocial deficits associated with traumatic brain injury (TBI) in the U.S. Despite extensive efforts to develop neuroprotective therapies for this devastating disorder, there have been no successful outcomes in human clinical trials to date. Retrospective studies have shown that \u03b2-adrenergic receptor blockers, specifically propranolol, significantly decrease mortality of TBI through mechanisms not yet fully elucidated but are thought to counterbalance a hyperadrenergic state resulting from a TBI. Conversely, cellular therapies have been shown to improve long-term behavior following TBI, likely by reducing inflammation. Given the nonredundancy in their therapeutic mechanisms, we hypothesized that a combination of acute propranolol followed by mesenchymal stem cells (MSCs) isolated from human bone marrow would have additive effects in treating a rodent model of TBI. We have found that the treatments are well-tolerated individually and in combination with no adverse events. MSCs decrease BBB permeability at 96 hours after injury, inhibit a significant accumulation of activated microglia\/macrophage in the thalamic region of the brain both short and long term, and enhance neurogenesis short term. Propranolol decreases edema and reduces the number of fully activated microglia at 7 days and the number of semiactivated microglia at 120 days. Combinatory treatment improved cognitive and memory functions 120 days following TBI. Therefore, the results here suggest a new, efficacious sequential treatment for TBI may be achieved using the \u03b2-blocker propranolol followed by MSC treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance<\/jats:title>\n                    <jats:p>Despite continuous efforts, traumatic brain injury (TBI) remains the leading cause of death and disability worldwide in patients under the age of 44. In this study, an animal model of moderate-severe TBI was treated with an acute dose of propranolol followed by a delayed dose of human mesenchymal stem cells (MSCs), resulting in improved short- and long-term measurements. These results have direct translational application. They reinforce the inevitable clinical trial of MSCs to treat TBI by demonstrating, among other benefits, a notable decrease in chronic neuroinflammation. More importantly, these results demonstrate that MSCs and propranolol, which is increasingly being used clinically for TBI, are compatible treatments that improve overall outcome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5966\/sctm.2015-0065","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T17:11:23Z","timestamp":1452186683000},"page":"33-44","source":"Crossref","is-referenced-by-count":64,"title":["Propranolol and Mesenchymal Stromal Cells Combine to Treat Traumatic Brain Injury"],"prefix":"10.1093","volume":"5","author":[{"given":"Daniel J.","family":"Kota","sequence":"first","affiliation":[{"name":"Department of Pediatric Surgery, University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik S.","family":"Prabhakara","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra J.","family":"van Brummen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supinder","family":"Bedi","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasen","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"DiCarlo","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Charles S.","family":"Cox","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Olson","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,11,19]]},"reference":[{"key":"2021122704441482600_R1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.nic.2010.08.001","article-title":"Head trauma","volume":"20","author":"Gean","year":"2010","journal-title":"Neuroimaging Clin N Am"},{"key":"2021122704441482600_R2","author":"Faul","year":"2010"},{"key":"2021122704441482600_R3","author":"Finkelstein","year":"2006"},{"key":"2021122704441482600_R4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/bja\/aem128","article-title":"Traumatic brain injury: Assessment, resuscitation and early management","volume":"99","author":"Moppett","year":"2007","journal-title":"Br J Anaesth"},{"key":"2021122704441482600_R5","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.bbi.2012.06.008","article-title":"Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention","volume":"26","author":"Kumar","year":"2012","journal-title":"Brain Behav Immun"},{"key":"2021122704441482600_R6","first-page":"315","article-title":"Neuropathological sequelae of traumatic brain injury: Relationship to neurochemical and biomechanical mechanisms","volume":"74","author":"McIntosh","year":"1996","journal-title":"Lab Invest"},{"key":"2021122704441482600_R7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1227\/NEU.0b013e318207734c","article-title":"Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children","volume":"68","author":"Cox","year":"2011","journal-title":"Neurosurgery"},{"key":"2021122704441482600_R8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1089\/neu.2008.0794","article-title":"Combination therapies for traumatic brain injury: Prospective considerations","volume":"26","author":"Margulies","year":"2009","journal-title":"J Neurotrauma"},{"key":"2021122704441482600_R9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nurt.2008.10.029","article-title":"Multifunctional drug treatment in neurotrauma","volume":"6","author":"Stoica","year":"2009","journal-title":"Neurotherapeutics"},{"key":"2021122704441482600_R10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/TA.0b013e31802d02d0","article-title":"Beta-blocker exposure is associated with improved survival after severe traumatic brain injury","volume":"62","author":"Cotton","year":"2007","journal-title":"J Trauma"},{"key":"2021122704441482600_R11","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1089\/neu.2008.0628","article-title":"Hypermetabolism following moderate to severe traumatic acute brain injury: A systematic review","volume":"25","author":"Foley","year":"2008","journal-title":"J Neurotrauma"},{"key":"2021122704441482600_R12","first-page":"1602","article-title":"Sympathetic hyperactivity after traumatic brain injury and the role of beta-blocker therapy","volume":"69","author":"Heffernan","year":"2010","journal-title":"J Trauma"},{"key":"2021122704441482600_R13","first-page":"CD006686","article-title":"Beta-2 receptor antagonists for acute traumatic brain injury","author":"Ker","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"2021122704441482600_R14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/TA.0b013e31825a769b","article-title":"\u03b2-Adrenergic receptor inhibition affects cerebral glucose metabolism, motor performance, and inflammatory response after traumatic brain injury","volume":"73","author":"Ley","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"key":"2021122704441482600_R15","first-page":"154","article-title":"The in vivo effect of propranolol on cerebral perfusion and hypoxia after traumatic brain injury","volume":"66","author":"Ley","year":"2009","journal-title":"J Trauma"},{"key":"2021122704441482600_R16","first-page":"503","article-title":"Beta-blocker exposure in patients with severe traumatic brain injury (TBI) and cardiac uncoupling","volume":"63","author":"Riordan","year":"2007","journal-title":"J Trauma"},{"key":"2021122704441482600_R17","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.3171\/FOC.2008.25.10.E8","article-title":"Beta blockers exposure and traumatic brain injury: A literature review","volume":"25","author":"Tran","year":"2008","journal-title":"Neurosurg Focus"},{"key":"2021122704441482600_R18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/TA.0000000000000104","article-title":"Traumatic brain injury and \u03b2-blockers: Not all drugs are created equal","volume":"76","author":"Schroeppel","year":"2014","journal-title":"J Trauma Acute Care Surg"},{"key":"2021122704441482600_R19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1745-6215-13-177","article-title":"Decreasing adrenergic or sympathetic hyperactivity after severe traumatic brain injury using propranolol and clonidine (DASH After TBI Study): Study protocol for a randomized controlled trial","volume":"13","author":"Patel","year":"2012","journal-title":"Trials"},{"key":"2021122704441482600_R20","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/mt.2008.93","article-title":"In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors","volume":"16","author":"Bauer","year":"2008","journal-title":"Mol Ther"},{"key":"2021122704441482600_R21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/mt.2011.211","article-title":"Mesenchymal stem\/stromal cells (MSCs): Role as guardians of inflammation","volume":"20","author":"Prockop","year":"2012","journal-title":"Mol Ther"},{"key":"2021122704441482600_R22","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni.3002","article-title":"Plasticity of mesenchymal stem cells in immunomodulation: Pathological and therapeutic implications","volume":"15","author":"Wang","year":"2014","journal-title":"Nat Immunol"},{"key":"2021122704441482600_R23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.forsciint.2004.06.027","article-title":"Long-term intracerebral inflammatory response after traumatic brain injury","volume":"146","author":"Gentleman","year":"2004","journal-title":"Forensic Sci Int"},{"key":"2021122704441482600_R24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/brain\/aws322","article-title":"Inflammation and white matter degeneration persist for years after a single traumatic brain injury","volume":"136","author":"Johnson","year":"2013","journal-title":"Brain"},{"key":"2021122704441482600_R25","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/ana.22455","article-title":"Inflammation after trauma: Microglial activation and traumatic brain injury","volume":"70","author":"Ramlackhansingh","year":"2011","journal-title":"Ann Neurol"},{"key":"2021122704441482600_R26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1742-2094-10-106","article-title":"Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury","volume":"10","author":"Zhang","year":"2013","journal-title":"J Neuroinflammation"},{"key":"2021122704441482600_R27","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/stem.118","article-title":"Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression","volume":"27","author":"Ren","year":"2009","journal-title":"Stem Cells"},{"key":"2021122704441482600_R28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.intimp.2012.03.024","article-title":"Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells","volume":"13","author":"Lee","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"2021122704441482600_R29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2141.2005.05409.x","article-title":"Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells","volume":"129","author":"Puissant","year":"2005","journal-title":"Br J Haematol"},{"key":"2021122704441482600_R30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/scrt336","article-title":"Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells","volume":"4","author":"Ribeiro","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"2021122704441482600_R31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cellimm.2009.06.010","article-title":"Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues","volume":"259","author":"Yoo","year":"2009","journal-title":"Cell Immunol"},{"key":"2021122704441482600_R32","doi-asserted-by":"crossref","first-page":"16766","DOI":"10.1073\/pnas.1416121111","article-title":"TSG-6 as a biomarker to predict efficacy of human mesenchymal stem\/progenitor cells (hMSCs) in modulating sterile inflammation in vivo","volume":"111","author":"Lee","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122704441482600_R33","doi-asserted-by":"crossref","first-page":"953","DOI":"10.5966\/sctm.2013-0100","article-title":"Intravenous multipotent adult progenitor cell therapy attenuates activated microglial\/macrophage response and improves spatial learning after traumatic brain injury","volume":"2","author":"Bedi","year":"2013","journal-title":"Stem Cells Translational Medicine"},{"key":"2021122704441482600_R34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1634\/stemcells.20-6-530","article-title":"Expansion of human adult stem cells from bone marrow stroma: Conditions that maximize the yields of early progenitors and evaluate their quality","volume":"20","author":"Sekiya","year":"2002","journal-title":"Stem Cells"},{"key":"2021122704441482600_R35","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/1742-2094-9-228","article-title":"Intravenous multipotent adult progenitor cell therapy after traumatic brain injury: Modulation of the resident microglia population","volume":"9","author":"Walker","year":"2012","journal-title":"J Neuroinflammation"},{"key":"2021122704441482600_R36","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jss.2014.05.011","article-title":"Far-red tracer analysis of traumatic cerebrovascular permeability","volume":"190","author":"Liao","year":"2014","journal-title":"J Surg Res"},{"key":"2021122704441482600_R37","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/TA.0b013e31829617c6","article-title":"Autologous bone marrow mononuclear cells therapy attenuates activated microglial\/macrophage response and improves spatial learning after traumatic brain injury","volume":"75","author":"Bedi","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"2021122704441482600_R38","first-page":"353","article-title":"In vivo effect of propranolol dose and timing on cerebral perfusion after traumatic brain injury","volume":"68","author":"Ley","year":"2010","journal-title":"J Trauma"},{"key":"2021122704441482600_R39","first-page":"386","article-title":"Protective effects of propranolol on experimentally head-injured mouse brains","volume":"94","author":"Liu","year":"1995","journal-title":"J Formos Med Assoc"},{"key":"2021122704441482600_R40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrneurol.2010.74","article-title":"Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury","volume":"6","author":"Shlosberg","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"2021122704441482600_R41","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.tips.2010.09.005","article-title":"Neuroprotection for traumatic brain injury: Translational challenges and emerging therapeutic strategies","volume":"31","author":"Loane","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"2021122704441482600_R42","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1097\/00001756-200008030-00047","article-title":"Cell activation and inflammatory response following traumatic axonal injury in the rat","volume":"11","author":"Csuka","year":"2000","journal-title":"Neuroreport"},{"key":"2021122704441482600_R43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s004019900172","article-title":"Dynamics of microglial activation after human traumatic brain injury are revealed by delayed expression of macrophage-related proteins MRP8 and MRP14","volume":"100","author":"Engel","year":"2000","journal-title":"Acta Neuropathol"},{"key":"2021122704441482600_R44","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1126\/science.287.5457.1433","article-title":"Mammalian neural stem cells","volume":"287","author":"Gage","year":"2000","journal-title":"Science"},{"key":"2021122704441482600_R45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.276.5309.66","article-title":"Stem cells in the central nervous system","volume":"276","author":"McKay","year":"1997","journal-title":"Science"},{"key":"2021122704441482600_R46","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1523\/JNEUROSCI.16-06-02027.1996","article-title":"Neurogenesis in the dentate gyrus of the adult rat: Age-related decrease of neuronal progenitor proliferation","volume":"16","author":"Kuhn","year":"1996","journal-title":"J Neurosci"},{"key":"2021122704441482600_R47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1460-9568.2004.03813.x","article-title":"Doublecortin expression levels in adult brain reflect neurogenesis","volume":"21","author":"Couillard-Despres","year":"2005","journal-title":"Eur J Neurosci"},{"key":"2021122704441482600_R48","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMoa010342","article-title":"Reversal of catabolism by beta-blockade after severe burns","volume":"345","author":"Herndon","year":"2001","journal-title":"N Engl J Med"},{"key":"2021122704441482600_R49","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1089\/neu.1997.14.839","article-title":"Time course of cerebral edema after traumatic brain injury in rats: Effects of riluzole and mannitol","volume":"14","author":"Bareyre","year":"1997","journal-title":"J Neurotrauma"},{"key":"2021122704441482600_R50","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neuroscience.2004.06.046","article-title":"Edema and brain trauma","volume":"129","author":"Unterberg","year":"2004","journal-title":"Neuroscience"},{"key":"2021122704441482600_R51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF01757299","article-title":"The activity of the sympathetic nervous system following severe head injury","volume":"6","author":"H\u00f6rtnagl","year":"1980","journal-title":"Intensive Care Med"},{"key":"2021122704441482600_R52","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1089\/scd.2009.0353","article-title":"Characterization of monoamine oxidases in mesenchymal stem cells: Role in hydrogen peroxide generation and serotonin-dependent apoptosis","volume":"19","author":"Trouche","year":"2010","journal-title":"Stem Cells Dev"},{"key":"2021122704441482600_R53","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.bbamcr.2014.05.002","article-title":"Functional expression of adrenoreceptors in mesenchymal stromal cells derived from the human adipose tissue","volume":"1843","author":"Kotova","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"2021122704441482600_R54","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1359-6101(98)00015-X","article-title":"Cytokine actions in the central nervous system","volume":"9","author":"Benveniste","year":"1998","journal-title":"Cytokine Growth Factor Rev"},{"key":"2021122704441482600_R55","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ar.a.10069","article-title":"Morphological features in human cortical brain microvessels after head injury: A three-dimensional and immunocytochemical study","volume":"273","author":"Rodr\u00edguez-Baeza","year":"2003","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"key":"2021122704441482600_R56","doi-asserted-by":"crossref","first-page":"161ra150","DOI":"10.1126\/scitranslmed.3004660","article-title":"Mesenchymal stem cells regulate blood-brain barrier integrity through TIMP3 release after traumatic brain injury","volume":"4","author":"Menge","year":"2012","journal-title":"Sci Transl Med"},{"key":"2021122704441482600_R57","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12974-015-0284-x","article-title":"The inhibitory effect of mesenchymal stem cell on blood-brain barrier disruption following intracerebral hemorrhage in rats: Contribution of TSG-6","volume":"12","author":"Chen","year":"2015","journal-title":"J Neuroinflammation"},{"key":"2021122704441482600_R58","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"2021122704441482600_R59","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1182\/blood-2010-12-327353","article-title":"Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2\/NF-\u03baB signaling in resident macrophages","volume":"118","author":"Choi","year":"2011","journal-title":"Blood"},{"key":"2021122704441482600_R60","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.injury.2007.10.005","article-title":"Modulation of immune response by head injury","volume":"38","author":"Morganti-Kossmann","year":"2007","journal-title":"Injury"},{"key":"2021122704441482600_R61","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1126\/science.1190929","article-title":"Changing face of microglia","volume":"330","author":"Graeber","year":"2010","journal-title":"Science"},{"key":"2021122704441482600_R62","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1046\/j.0953-816x.2001.01470.x","article-title":"Nonactivated microglia promote oligodendrocyte precursor survival and maturation through the transcription factor NF-kappa B","volume":"13","author":"Nicholas","year":"2001","journal-title":"Eur J Neurosci"},{"key":"2021122704441482600_R63","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/glia.20419","article-title":"Microglia instruct subventricular zone neurogenesis","volume":"54","author":"Walton","year":"2006","journal-title":"Glia"},{"key":"2021122704441482600_R64","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.intimp.2010.09.001","article-title":"Bone marrow-derived mesenchymal stem cells modulate BV2 microglia responses to lipopolysaccharide","volume":"10","author":"Ooi","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"2021122704441482600_R65","doi-asserted-by":"crossref","first-page":"e84116","DOI":"10.1371\/journal.pone.0084116","article-title":"Bone marrow-derived mesenchymal stem cells maintain the resting phenotype of microglia and inhibit microglial activation","volume":"8","author":"Yan","year":"2013","journal-title":"PLoS One"},{"key":"2021122704441482600_R66","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1742-2094-11-135","article-title":"Mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through TSG-6","volume":"11","author":"Liu","year":"2014","journal-title":"J Neuroinflammation"},{"key":"2021122704441482600_R67","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.expneurol.2011.12.008","article-title":"Posttraumatic hypothermia increases doublecortin expressing neurons in the dentate gyrus after traumatic brain injury in the rat","volume":"233","author":"Bregy","year":"2012","journal-title":"Exp Neurol"},{"key":"2021122704441482600_R68","doi-asserted-by":"crossref","first-page":"e81585","DOI":"10.1371\/journal.pone.0081585","article-title":"Influence of post-traumatic stress disorder on neuroinflammation and cell proliferation in a rat model of traumatic brain injury","volume":"8","author":"Acosta","year":"2013","journal-title":"PLoS One"},{"key":"2021122704441482600_R69","doi-asserted-by":"crossref","first-page":"12901","DOI":"10.1523\/JNEUROSCI.4629-08.2008","article-title":"Traumatic brain injury-induced hippocampal neurogenesis requires activation of early nestin-expressing progenitors","volume":"28","author":"Yu","year":"2008","journal-title":"J Neurosci"},{"key":"2021122704441482600_R70","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/3305","article-title":"Neurogenesis in the adult human hippocampus","volume":"4","author":"Eriksson","year":"1998","journal-title":"Nat Med"},{"key":"2021122704441482600_R71","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuroscience.2012.12.038","article-title":"Neurorescue effects and stem properties of chorionic villi and amniotic progenitor cells","volume":"234","author":"Calzarossa","year":"2013","journal-title":"Neuroscience"},{"key":"2021122704441482600_R72","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neulet.2010.07.062","article-title":"Characterization of conditioned medium of cultured bone marrow stromal cells","volume":"483","author":"Nakano","year":"2010","journal-title":"Neurosci Lett"},{"key":"2021122704441482600_R73","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1007\/s00018-013-1290-8","article-title":"Mesenchymal stem cells secretome: A new paradigm for central nervous system regeneration?","volume":"70","author":"Teixeira","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"2021122704441482600_R74","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.scr.2009.02.006","article-title":"Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro","volume":"3","author":"Wilkins","year":"2009","journal-title":"Stem Cell Res (Amst)"},{"key":"2021122704441482600_R75","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11064-006-9212-x","article-title":"Human mesenchymal stem cells signals regulate neural stem cell fate","volume":"32","author":"Bai","year":"2007","journal-title":"Neurochem Res"},{"key":"2021122704441482600_R76","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1089\/hum.2013.001","article-title":"Bone-marrow-derived mesenchymal stem cells promote proliferation and neuronal differentiation of Niemann-Pick type C mouse neural stem cells by upregulation and secretion of CCL2","volume":"24","author":"Lee","year":"2013","journal-title":"Hum Gene Ther"},{"key":"2021122704441482600_R77","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1471-4159.2009.05886.x","article-title":"Inflammation mediates varying effects in neurogenesis: Relevance to the pathogenesis of brain injury and neurodegenerative disorders","volume":"108","author":"Whitney","year":"2009","journal-title":"J Neurochem"},{"key":"2021122704441482600_R78","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/01.jnen.0000229241.28619.75","article-title":"Thalamic nuclei after human blunt head injury","volume":"65","author":"Maxwell","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"2021122704441482600_R79","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1089\/neu.2011.1763","article-title":"Thalamus and cognitive impairment in mild traumatic brain injury: A diffusional kurtosis imaging study","volume":"29","author":"Grossman","year":"2012","journal-title":"J Neurotrauma"},{"key":"2021122704441482600_R80","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1212\/WNL.0b013e3181cff5d5","article-title":"Thalamic integrity underlies executive dysfunction in traumatic brain injury","volume":"74","author":"Little","year":"2010","journal-title":"Neurology"},{"key":"2021122704441482600_R81","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nature06041","article-title":"Behavioural improvements with thalamic stimulation after severe traumatic brain injury","volume":"448","author":"Schiff","year":"2007","journal-title":"Nature"},{"key":"2021122704441482600_R82","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-9-23","article-title":"TNF-\u03b1 protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation","volume":"9","author":"Belarbi","year":"2012","journal-title":"J Neuroinflammation"},{"key":"2021122704441482600_R83","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1586\/ern.11.113","article-title":"Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosis","volume":"11","author":"Darlington","year":"2011","journal-title":"Expert Rev Neurother"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2015-0065","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2015-0065","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/5\/1\/33\/41867375\/stcltm_5_1_33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/5\/1\/33\/41867375\/stcltm_5_1_33.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T21:49:41Z","timestamp":1642542581000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/5\/1\/33-44\/6397820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,19]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,11,19]]},"published-print":{"date-parts":[[2016,1,1]]}},"URL":"https:\/\/doi.org\/10.5966\/sctm.2015-0065","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,1,1]]},"published":{"date-parts":[[2015,11,19]]}}}